DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis

作者：Choi Hyeong Sim; Lee Kangwook; Kim Min Kyoung; Lee Kang Min; Shin Yong Cheol; Cho Sung Gook; Ko Seong Gyu

来源：Oncotarget, 2016, 7(16): 21775-21785.

DOI：10.18632/oncotarget.7982

• DSGOST
• angiogenesis
• tumor
• VEGF
• herbal medicine

Tumor growth requires a process called angiogenesis, a new blood vessel formation from pre-existing vessels, as newly formed vessels provide tumor cells with oxygen and nutrition. Danggui-Sayuk-Ga-Osuyu-Saenggang-Tang (DSGOST), one of traditional Chinese medicines, has been widely used in treatment of vessel diseases including Raynaud's syndrome in Northeast Asian countries including China, Japan and Korea. Therefore, we hypothesized that DSGOST might inhibit tumor growth by targeting newly formed vessels on the basis of its historical prescription. Here, we demonstrate that DSGOST inhibits tumor growth by inhibiting VEGF-induced angiogenesis. DSGOST inhibited VEGF-induced angiogenic abilities of endothelial cells in vitro and in vivo, which resulted from its inhibition of VEGF/VEGFR2 interaction. Furthermore, DSGOST attenuated pancreatic tumor growth in vivo by reducing angiogenic vessel numbers, while not affecting pancreatic tumor cell viability. Thus, our data conclude that DSGOST inhibits VEGF-induced tumor angiogenesis, suggesting a new indication for DSGOST in treatment of cancer.

• 出版日期2016-4-19